ChiCTR2200059087 版本V1.0 版本创建时间2022/04/24 01:09:24 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2200059087 

最近更新日期:

Date of Last Refreshed on:

2022-04-24 01:09:03 

注册时间:

Date of Registration:

2022-04-24 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

全麻复合硬膜外麻醉对结直肠癌患者预后的回顾性临床研究

Public title:

Retrospective Clinical Study on Prognosis of Colorectal cancer Patients with General Anesthesia Combined with Epidural Anesthesia

注册题目简写:

English Acronym:

研究课题的正式科学名称:

全麻复合硬膜外麻醉对结直肠癌患者预后的回顾性临床研究

Scientific title:

Retrospective Clinical Study on Prognosis of Colorectal cancer Patients with General Anesthesia Combined with Epidural Anesthesia

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

鲁显福 

研究负责人:

鲁显福 

Applicant:

Xian-Fu Lu 

Study leader:

Xian-Fu Lu 

申请注册联系人电话:

Applicant telephone:

18256031820

研究负责人电话:

Study leader's
telephone:

18256031820

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

lxf0001@126.com

研究负责人电子邮件:

Study leader's E-mail:

lxf0001@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

安徽省合肥市绩溪路218号

研究负责人通讯地址:

安徽省合肥市绩溪路218号

Applicant address:

218 Jixi Road, Shushan District, Hefei, Anhui, China

Study leader's address:

218 Jixi Road, Shushan District, Hefei, Anhui, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

安徽医科大学第一附属医院

Applicant's institution:

First Affiliated Hospital of Anhui Medical University

研究负责人所在单位:

Affiliation of the Leader:

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

PJ2022-02-43

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

安徽医科大学第一附属医院临床医学研究伦理委员会

Name of the ethic committee:

Ethics Committee of Clinical Medical Research, the First Affiliated Hospital of Anhui Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2022-02-17 00:00:00

伦理委员会联系人:

周涛

Contact Name of the ethic committee:

Tao Zhou

伦理委员会联系地址:

安徽医科大学第一附属医院行政楼6F

Contact Address of the ethic committee:

6F, Administration Building, The First Affiliated Hospital of Anhui Medical University, 218 Jixi Road, Shushan District, Hefei, Anhui, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

0551-62923537

伦理委员会联系人邮箱:

Contact email of the ethic committee:

331417268@qq.com

研究实施负责(组长)单位:

安徽医科大学第一附属医院

Primary sponsor:

The First Affiliated Hospital of Anhui Medical University

研究实施负责(组长)单位地址:

安徽省合肥市绩溪路218号

Primary sponsor's address:

218 Jixi Road, Shushan District, Hefei, Anhui, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

安徽

市(区县):

合肥

Country:

China

Province:

Anhui

City:

Hefei

单位(医院):

安徽医科大学第一附属医院

具体地址:

安徽省合肥市蜀山区绩溪路218号

Institution
hospital:

First Affiliated Hospital of Anhui Medical University

Address:

218 Jixi Road, Shushan District, Hefei, Anhui

经费或物资来源:

安徽医科大学第一附属医院院长基金

Source(s) of funding:

Dean's Fund of the First Affiliated Hospital of Anhui Medical University

研究疾病:

结直肠癌  

Target disease:

colorectal cancer

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

回顾性研究 

Study phase:

Retrospective study

研究设计:

病例对照研究 

Study design:

Case-Control study 

研究目的:

研究全麻复合硬膜外麻醉方式与结直肠癌患者预后之间关系的回顾性临床研究。  

Objectives of Study:

A retrospective clinical study to study the relationship between general anesthesia combined with epidural anesthesia and the prognosis of patients with colorectal cancer.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1. 患者一般情况尚可(如血红蛋白大于90g/L,血清蛋白大于30g/L,肝肾功能良好),无重要脏器严重功能障碍,无恶液质、自身免疫性或免疫缺陷性疾病、感染、严重精神障碍等系统性疾病;
2. 术前肠镜病理报告确诊结直肠恶性肿瘤,胸腹盆腔CT平扫加增强提示无远处脏器转移。

Inclusion criteria

1. The general condition of the patient is fair (such as hemoglobin greater than 90g/L, serum protein greater than 30g/L, and good liver and kidney function), no serious dysfunction of important organs, no cachexia, autoimmune or immunodeficiency diseases, Systemic diseases such as infections and severe mental disorders;
2. The preoperative colonoscopy pathology report confirmed the diagnosis of colorectal malignant tumors. CT scans of the chest, abdomen and pelvis plus enhanced showed that there was no distant organ metastasis.

排除标准:

2.5.1.1入选本研究前3个月内参与了其他药物临床试验或其他麻醉治疗试验的志愿者;
2.5.1.2 电话随访,拒绝接受本研究或处于育龄、妊娠期的女性患者;
2.5.1.3本研究排除多脏器切除或其他消化道疾病或恶性肿瘤患者;
2.5.1.4接受过器官移植的患者;
2.5.1.5曾经有手术史且发生过严重并发症和不良麻醉手术史的患者。

Exclusion criteria:

2.5.1.1 Volunteers who participated in other drug clinical trials or other anesthesia treatment trials within 3 months before being selected for this study;
2.5.1.2 Telephone follow-up, female patients who refuse to accept this study or are of childbearing age or pregnancy;
2.5.1.3 This study excluded patients with multiple organ resection or other digestive tract diseases or malignant tumors;
2.5.1.4 Patients who have received organ transplantation;
2.5.1.5 Patients who have had a history of surgery and have had serious complications and a history of poor anesthesia surgery.

研究实施时间:

Study execute time:

From 2021-12-01 00:00:00 To 2023-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2022-06-01 00:00:00 To 2023-12-31 00:00:00

干预措施:

Interventions:

组别:

全麻+硬膜外实验组

样本量:

759

Group:

General anesthesia + epidural test group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

组别:

全身麻醉对照组

样本量:

759

Group:

General anesthesia Control group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

安徽 

市(区县):

合肥 

Country:

China

Province:

Anhui

City:

Hefei

单位(医院):

安徽医科大学第一附属医院 

单位级别:

三甲 

Institution
hospital:

First Affiliated Hospital of Anhui Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

围手术期外科相关并发症

指标类型:

主要指标

Outcome:

Surgery-related complications during perioperative period

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

围手术期麻醉相关并发症

指标类型:

主要指标

Outcome:

Anesthesia-related complications during the perioperative period

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肿瘤患者长期预后

指标类型:

附加指标

Outcome:

Long-term prognosis of cancer patients

Type:

Additional indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

搜集2017年10月-2021年10月在安徽医科大学第一附属医院接受结直肠癌手术的患者,按照其麻醉方式分为全麻+硬膜外实验组、全身麻醉对照组。

Randomization Procedure (please state who generates the random number sequence and by what method):

Patients who underwent colorectal cancer surgery in the First Affiliated Hospital of Anhui Medical University from October 2017 to October 2021 were collected and divided into general anesthesia + epidural experimental group and general anesthesia control group according to their anesthesia methods.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

试验完成后可以给主要负责人发邮件索取原始数据

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

After the test is completed, you can email the main person in charge to request the original data

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病历记录表,安徽医科大学第一附属医院电子病历系统

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form, CRF, electronic medical record system of the First Affiliated Hospital of Anhui Medical University

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2022-04-24 01:09:03